Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (1011-1020 of 1,052) with videos related to

Pageof 106
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute LeukemiaAnthony Stein, Joycelynne Palmer, Ni-Chun Tsai, et al.
Bone Marrow Transplantation|February 27, 2025
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effectPaul B Koller, Tamer Othman, Dongyun Yang, et al.
Frontiers in Immunology|March 20, 2023
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, et al.
Blood|April 28, 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHLXiuli Wang, Leslie L Popplewell, Jamie R Wagner, et al.
Nature Communications|August 7, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, John P Murad, Lea Christian, et al.
Transplantation and Cellular Therapy|September 27, 2024
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete RemissionZaid Abdel Rahman, Tamer Othman, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2017
Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative StudyMohamed A Kharfan-Dabaja, Renju Raj, Liana Nikolaenko, et al.
Cancer Immunology Research|October 23, 2020
The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic LymphomaXiuli Wang, Christian Huynh, Ryan Urak, et al.
Journal for Immunotherapy of Cancer|May 22, 2023
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemiaAnil Kumar, Adeleh Taghi Khani, Caroline Duault, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal ImpairmentTina Nguyen, Tanya Markary, Ni-Chun Tsai, et al.
Pageof 106

Showing results (1011-1020 of 1,052) with videos related to

Sort By:
Pageof 106
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute LeukemiaAnthony Stein, Joycelynne Palmer, Ni-Chun Tsai, et al.
Bone Marrow Transplantation|February 27, 2025
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effectPaul B Koller, Tamer Othman, Dongyun Yang, et al.
Frontiers in Immunology|March 20, 2023
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, et al.
Blood|April 28, 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHLXiuli Wang, Leslie L Popplewell, Jamie R Wagner, et al.
Nature Communications|August 7, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, John P Murad, Lea Christian, et al.
Transplantation and Cellular Therapy|September 27, 2024
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete RemissionZaid Abdel Rahman, Tamer Othman, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2017
Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative StudyMohamed A Kharfan-Dabaja, Renju Raj, Liana Nikolaenko, et al.
Cancer Immunology Research|October 23, 2020
The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic LymphomaXiuli Wang, Christian Huynh, Ryan Urak, et al.
Journal for Immunotherapy of Cancer|May 22, 2023
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemiaAnil Kumar, Adeleh Taghi Khani, Caroline Duault, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal ImpairmentTina Nguyen, Tanya Markary, Ni-Chun Tsai, et al.
Pageof 106